The mechanism underpinning the immunoregulatory effect of stem cell transplantation, particularly CST1-based intervention, will shed light on the development of new therapeutic strategies for curing liver diseases or other diseases that involve IFN over-activation. The gene discussed is IFNA1; the disease is liver disorder.